September 16, 2019

Model-Based TDM In Oncology

I recently gave a talk at the 2nd International Workshop on Clinical Pharmacology of Anticancer Drugs in Madrid on the topic of Model-based TDM in Oncology.

In the talk I provided some background on model-based dosing in general, and presented some specific case studies in oncology (mainly around imatinib and busulfan). I also pointed at some future opportunities in model-informed precision dosing in oncology.

The slides of this talk are provided in this link. Feel free to reach out with any feedback!

Ron Keizer, PHD, PharmD
About the Author: Ron Keizer, PHD, PharmD

CSO and Co-Founder